Details for New Drug Application (NDA): 090951
✉ Email this page to a colleague
The generic ingredient in EPINASTINE HYDROCHLORIDE is epinastine hydrochloride. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the epinastine hydrochloride profile page.
Summary for 090951
Tradename: | EPINASTINE HYDROCHLORIDE |
Applicant: | Somerset Theraps Llc |
Ingredient: | epinastine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 090951
Mechanism of Action | Adrenergic Agonists Histamine H1 Receptor Antagonists |
Physiological Effect | Decreased Histamine Release |
Suppliers and Packaging for NDA: 090951
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
EPINASTINE HYDROCHLORIDE | epinastine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 090951 | ANDA | Somerset Therapeutics, LLC | 70069-008 | 70069-008-10 | 10 CARTON in 1 CARTON (70069-008-10) / 1 BOTTLE in 1 CARTON (70069-008-01) / 5 mL in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.05% | ||||
Approval Date: | Oct 31, 2011 | TE: | AT | RLD: | No |
Complete Access Available with Subscription